Gainers
- Atreca (NASDAQ:BCEL) stock rose 52.7% to $0.36 during Monday's regular session. The market value of their outstanding shares is at $14.1 million.
- Cyclo Therapeutics (NASDAQ:CYTH) shares rose 29.51% to $1.86. The market value of their outstanding shares is at $53.3 million.
- Elevation Oncology (NASDAQ:ELEV) stock moved upwards by 27.35% to $2.7. The market value of their outstanding shares is at $114.5 million.
- Y-mAbs Therapeutics (NASDAQ:YMAB) shares rose 27.29% to $9.59. The market value of their outstanding shares is at $418.1 million.
- Cadrenal Therapeutics (NASDAQ:CVKD) stock rose 22.46% to $0.75. The market value of their outstanding shares is at $9.7 million.
- ASLAN Pharma (NASDAQ:ASLN) shares rose 19.21% to $0.94. The market value of their outstanding shares is at $15.7 million.
Losers
- MAIA Biotechnology (AMEX:MAIA) shares declined by 22.0% to $1.1 during Monday's regular session. The market value of their outstanding shares is at $18.6 million.
- Sonoma Pharmaceuticals (NASDAQ:SNOA) shares decreased by 20.86% to $0.18. The market value of their outstanding shares is at $2.5 million.
- Ekso Bionics Holdings (NASDAQ:EKSO) stock declined by 16.51% to $1.67. The market value of their outstanding shares is at $23.7 million.
- Avalo Therapeutics (NASDAQ:AVTX) stock fell 15.43% to $5.81. The company's market cap stands at $4.6 million.
- Cyclacel Pharmaceuticals (NASDAQ:CYCC) shares fell 15.11% to $2.36. The company's market cap stands at $2.4 million.
- Venus Concept (NASDAQ:VERO) stock fell 14.5% to $1.18. The market value of their outstanding shares is at $6.5 million. See Also:
This article was generated by Benzinga's automated content engine and reviewed by an editor.